Skip to content

A targeted community program of vitamin D treatment to reduce hospital admissions for falls, fractures and other disorders

A randomised controlled placebo-controlled study to evaluate the effects of vitamin D treatment on reducing hospital admissions for falls, fractures and other disorders in elderly women

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12609000748213
Enrollment
660
Registered
2009-08-28
Start date
2009-02-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a nine-month randomised controlled study to evaluate the effects of vitamin D 150,000 IU per three months on risk of falling, serum vitamin D levels, mobility function and muscle strength in women aged 70 years and over at a community setting.

Interventions

150,000 IU vitamin D (cholecalciferol) taken orally as 3 capsules at three clinic visits three months apart; lifestyle advice on physical activity and calcium intake given at baseline through an information sheet administered by trained research assistants

Sponsors

Professor RL Prince
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
70 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Females age over 70; 2. a) Registered with a General Practitioner (GP) attached to the practices selected for the study or b) Registered with a General Practitioner and able to contact her General Practitioner in Perth; 3. Likely to be able to attend their General Practitioner practice or Sir Charles Gairdner Hospital for four study visits over nine months.

Exclusion criteria

1. Consuming a vitamin D supplement either in isolation or as part of a combination treatment of greater than 200 IU per day, eg. Actonel combi +D or Fosamax plus; 2. A mini mental state score of less than 24; 3. Individuals who in the investigators opinion would not be suitable for the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026